Low- and high-dose fluticasone propionate in asthma; effects during and after treatment
Authors:
- Hh WongHWHh Wong
- Jt LiuJLJt Liu
- Jv FahyJFJv Fahy
- 1 January 2000
- journal article
- clinical trial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 15 (1) , 11-18
Abstract
The dose dependency of the effects of inhaled corticosteroids on markers of asthmatic airway inflammation have not been well studied. There is a need to study the dose/response effects on this inflammation. In order to determine the dose/response effects of fluticasone propionate (FP), 24 asthmatic subjects were randomized to low- (100 microg x day(-1)) or high-dose (1,000 microg x day(-1)) FP for six weeks followed by placebo for 3 weeks. During treatment, the median increase in forced expiratory volume in one second (FEV1)was 12% in the high-dose group (p<0.05) and 10% in the low-dose group (p0.05 between groups); the median decrease in the percentage of sputum eosinophils was 93% in the high-dose group (p<0.05) and 46% in the low-dose group (p0.05 between groups). Symptoms, salbutamol use, morning peak flow, provocative concentration of methacholine causing a 20% fall in FEV1 (PC20), sputum eosinophil cationic protein concentration and tryptase activity improved significantly in both groups (p<0.05), but only the improvement in salbutamol use was greater in the high-dose group (p<0.05). During the run-out, the improvements in FEV1 and PC20 were rapidly reversed in both groups, but the improvements in peak flow and tryptase activity persisted; the improvement in sputum eosinophil concentration persisted only in the high-dose group (p<0.05). It was concluded that dose/response effects for FP are not easily demonstrable because low-dose FP is quite effective. For most outcomes, the effects of high- and low-dose FP are relatively short-lived after treatment is stopped. This finding raises questions about the extent to which inhaled corticosteroids are disease-modifying in asthma.Keywords
This publication has 21 references indexed in Scilit:
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging studyClinical Therapeutics, 1996
- Comparison of Addition of Salmeterol to Inhaled Steroids With Doubling of the Dose of Inhaled SteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Effect of High Dose Inhaled Fluticasone Propionate on Airway Inflammation in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Budesonide treatment of moderate and severe asthma in children: A dose-response studyJournal of Allergy and Clinical Immunology, 1995
- Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjectsJournal of Allergy and Clinical Immunology, 1994
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Placebo-Controlled Immunopathologic Study of Four Months of Inhaled Corticosteroids in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1994
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- AEROSOL BECLOMETHASONE DIPROPIONATE: A DOSE-RESPONSE STUDY IN CHRONIC BRONCHIAL ASTHMAThe Lancet, 1973